Genetic Disorders and the Fetus. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Genetic Disorders and the Fetus - Группа авторов страница 40

Genetic Disorders and the Fetus - Группа авторов

Скачать книгу

      Feelings of guilt invariably invade the genetic consultation. They should be anticipated, recognized, and dealt with directly. Assurance frequently does not suffice; witness the implacable guilt of the obligate maternal carrier of a serious X‐linked disease.221 Explanations that we all carry harmful genes often helps. Mostly, however, encouragement to move anguish into action is important. This might also help in assuaging any blame by the partner in such cases.222

      Guilt is not only the preserve of the obligate carrier. Affected parents inevitably also experience guilt on transmitting their defective genes.223, 224 Frequently, parents express guilt about an occupation, medication, or illegal drug that they feel has caused or contributed to their child's problem. Kessler et al.224 advised that assuaging a parent's guilt may diminish their power of effective prevention, in that guilt may serve as a defense from being powerless.

      Guilt is often felt by healthy siblings of an affected child, who feel relatively neglected by their parents and who also feel anger toward their parents and affected sibling. “Survivor guilt” is increasingly recognized, as the new DNA technologies are exploited. Experience with Huntington disease and adult polycystic kidney disease225231 confirm not only survivor guilt with a new reality (a future) but also problems in relationships with close family members. Huggins et al.228 found that about 10 percent of individuals receiving low‐risk results experienced psychologic difficulties.

      Eleven key principles are discussed that guide genetic counseling in the preconception, prenatal, and perinatal periods. This section is in concert with consensus statements concerning ethical principles for genetics professionals232234 and surveyed international guidelines.235

      Accurate diagnosis

      Awareness of genetic heterogeneity and of intra‐ and inter‐family phenotypic variation of a specific disorder (e.g. tuberous sclerosis)247 is also necessary. The assumption of a particular predominant genotype as an explanation for a familial disorder is unwarranted. The common adult dominant polycystic kidney disease caused by mutations in the ADPKD1 gene has an early‐infancy presentation in 2–5 percent of cases.248 Moreover, mutations in the ADPKD2 gene may result in polycystic kidney disease and perinatal death249 and, further, should not be confused with the autosomal recessive type caused by mutations in the ARPKD gene. Awareness of contiguous gene syndromes, such as tuberous sclerosis and polycystic kidney disease (TSC2‐PKD1) is important, especially with the availability of microarrays.

      Instead of simply accepting the patient's naming of the disease (e.g. muscular dystrophy or a mucopolysaccharidosis), or that a test result was normal (or not), the counselor must obtain and document confirmatory data. The unreliability of the maternal history, in this context, is remarkable, a positive predictive value of 47 percent having been documented.250 Photographs of the deceased, autopsy reports, hospital records, results of carrier detection or other tests performed elsewhere, and other information may provide the crucial confirmation or negation of the diagnosis made previously. Important data after miscarriage may also influence counseling. In a study of 91 consecutive, spontaneously aborted fetuses, almost one‐third had malformations, most associated with increased risks in subsequent pregnancies.251

      Myotonic muscular dystrophy type 1 (DM), the most common adult muscular dystrophy, with an incidence of about 1 in 8,000,252 serves as the paradigm for preconception, prenatal, and perinatal genetic counseling. Recognition of the pleiomorphism of this disorder will, for example, alert the physician hearing a family history of one individual with DM, another with sudden death (cardiac conduction defect), and yet another relative with cataracts. Awareness of the autosomal dominant nature of this disorder and its genetic basis due to a dynamic mutation in the DMPK gene reflected in the number of trinucleotide (CTG) repeat units, raises issues beyond the 50 percent risk of recurrence in the offspring of an affected parent. As the first disorder characterized with expanding trinucleotide repeats, the observation linking the degree of disease severity and earlier onset to the number of triplet repeats was not long in coming252 (see Chapter 14). In addition, the differences in severity when the mutation was passed via a maternal rather than a paternal gene focused attention on the fact that congenital DM was almost always a sign of the greatest severity when originating through maternal transmission. However, at least one exception has been noted.253 There is about a 93–94 percent likelihood that the CTG repeat will expand on transmission. This process of genetic anticipation (increasing clinical severity over generations) is not inevitable. An estimated 6–7 percent of cases of DM are associated with a decrease in the number of triplet repeats or no change in number.254 Rare cases also exist in which complete reversal of the mutation occurs with spontaneous correction to a normal range of triplet repeats.255262

      Nondirective counseling

Скачать книгу